A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
NCT07255638
·
clinicaltrials.gov ↗
RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Indolent Systemic Mastocytosis
Interventions
DRUG:
Avapritinib
Sponsor
Blueprint Medicines Corporation